GlycanAge: Measuring Biological Age Through Your Immune System’s Sugar Coating

While most biological age tests measure DNA methylation, GlycanAge uses a fundamentally different biomarker: the sugar molecules coating your antibodies. This glycan-based approach reveals immune system aging in a way that epigenetic clocks cannot.

Presented By Our Partners

Every antibody in your bloodstream carries a coat of sugar molecules called glycans that fundamentally alter how the immune system behaves. These glycan structures are not static decorations; they shift predictably with age, inflammation, and metabolic health, effectively reprogramming antibody function from protective to inflammatory as the body ages. Immunoglobulin G (IgG), the most abundant antibody in human blood, undergoes a particularly well-characterized glycan transformation: younger, healthier immune systems produce IgG with complex, anti-inflammatory glycan structures, while aging and inflammation drive a shift toward simpler, pro-inflammatory glycan patterns. This transition is measurable, quantifiable, and, importantly, reversible through lifestyle intervention. GlycanAge, developed from over two decades of glycobiology research at the University of Zagreb in Croatia, translates this science into a consumer biological age test that approaches aging from a dimension that DNA methylation clocks do not capture: the functional state of the immune system itself.

What Is GlycanAge?

GlycanAge is an at-home biological age test that measures the glycan composition of immunoglobulin G (IgG) antibodies in a blood sample to estimate biological age and immune system health. Users collect a small blood sample via finger prick using the provided kit, mail it to GlycanAge’s laboratory, and receive results through an online dashboard within approximately 3 to 5 weeks.

The test analyzes the specific glycan structures attached to IgG antibodies, focusing on the ratio of anti-inflammatory to pro-inflammatory glycan types. The primary output is a GlycanAge score: the estimated biological age of the user’s immune system. A GlycanAge score younger than chronological age indicates a more anti-inflammatory, functionally younger immune profile. A score older than chronological age suggests accelerated immune aging and increased systemic inflammation.

GlycanAge offers two pricing tiers: the single test ($299) for a one-time snapshot, and the two-test package ($499) designed for baseline measurement followed by a retest after implementing lifestyle changes. The company emphasizes longitudinal tracking, recommending retesting after 3 to 6 months of intervention to assess whether immune glycan profiles have shifted toward a younger, less inflammatory pattern.

The Science Behind It: Glycobiology and Immune Aging

The science underlying GlycanAge represents a distinct branch of aging biology from the DNA methylation approach used by TruDiagnostic and Elysium. While epigenetic clocks measure chemical modifications to DNA that accumulate with age, glycan analysis measures changes in the sugar structures decorating proteins on the surface of immune cells and antibodies. Both are valid biomarkers of biological aging, but they capture different biological processes.

IgG glycosylation has been studied extensively in population-level cohorts. Research from the University of Zagreb and collaborating institutions has demonstrated that IgG glycan composition changes predictably with age: galactosylation and sialylation (associated with anti-inflammatory function) decrease, while agalactosylated glycans (associated with pro-inflammatory function) increase. These changes are not merely cosmetic; they directly alter how IgG interacts with Fc receptors on immune cells, shifting the balance between immune tolerance and immune activation. In practical terms, this glycan shift contributes to the chronic, low-grade inflammation (sometimes called “inflammaging”) that is increasingly recognized as a driver of cardiovascular disease, cancer, neurodegeneration, and metabolic dysfunction.

Crucially, IgG glycan profiles respond to lifestyle interventions more rapidly than DNA methylation patterns. Studies have shown that weight loss, improved nutrition, regular exercise, and stress reduction can shift IgG glycan profiles toward younger, more anti-inflammatory patterns within months. This responsiveness makes glycan-based biological age testing particularly well-suited for longitudinal tracking of intervention effectiveness, potentially offering a faster feedback loop than methylation-based clocks.

The limitation of glycan-based aging measurement is its narrower biological scope. DNA methylation clocks aggregate aging signals from across the genome, capturing information about multiple organ systems and biological processes. Glycan analysis focuses specifically on the immune system’s functional state. Both perspectives are valuable, and they are complementary rather than competing: a comprehensive approach to biological age assessment would include both methylation and glycan measurements. That is the science. Here is how GlycanAge applies it.

What GlycanAge Does Well

GlycanAge’s primary strength is its unique biomarker perspective. In a market where every competitor uses some version of DNA methylation analysis, GlycanAge provides genuinely different biological information. The immune system is a central mediator of aging-related disease, and measuring its functional state through glycan composition adds a dimension that methylation clocks, by design, do not capture. For users who already have epigenetic age data, GlycanAge provides complementary information that enriches the overall picture.

The responsiveness of glycan profiles to lifestyle intervention is a significant practical advantage. Because IgG glycan patterns can shift within months (compared to the slower changes in DNA methylation), GlycanAge may provide earlier feedback on whether nutritional, exercise, or stress management changes are producing immune system benefits. This faster feedback loop can be motivating for users who want to see measurable results from their health investments.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

The inflammation focus is clinically relevant. Chronic systemic inflammation is increasingly recognized as a common pathway linking the Four Shadows of cardiovascular disease, cancer, neurodegenerative disease, and metabolic dysfunction. A test that directly measures the immune system’s inflammatory balance provides information that traditional inflammation markers (like C-reactive protein) capture only crudely. GlycanAge’s specificity to IgG glycosylation offers a more nuanced view of immune function than broad inflammatory markers.

Pricing, Access, and Practical Realities

GlycanAge offers a single test for approximately $299 and a two-test package for approximately $499. The two-test package is designed for baseline-plus-retest use, providing the longitudinal comparison that maximizes the test’s value. No subscription is required.

The test uses a finger-prick blood collection kit mailed from and returned to GlycanAge’s laboratory. Results are delivered within 3 to 5 weeks through an online dashboard. No physician order is required. GlycanAge is not currently listed as HSA or FSA eligible, and it carries no FDA clearance or medical device designation. Results are classified as informational wellness data.

GlycanAge is headquartered in the United Kingdom with laboratory operations in Croatia, which may introduce longer shipping times for users in certain geographies. The test is available internationally, and the company provides prepaid return shipping for the blood collection kit.

Who GlycanAge Is Best For

GlycanAge is ideal for longevity-focused individuals who want a biological age measurement that specifically reflects immune system health and inflammatory status. It suits users who already have methylation-based epigenetic age data and want a complementary perspective. People implementing anti-inflammatory lifestyle interventions (dietary changes, exercise programs, stress reduction techniques) will find the glycan-based feedback loop valuable for assessing intervention effectiveness. Those with chronic inflammatory conditions or autoimmune concerns may find the immune-specific focus more relevant to their health priorities than a general methylation clock.

Those who should consider alternatives include users who want a single, comprehensive biological age test covering multiple dimensions of aging; TruDiagnostic TruAge Complete ($499) provides more algorithms and broader biological coverage through methylation analysis. Anyone seeking genetic (not biological age) testing needs an entirely different product. Users who want the most affordable entry point to biological age testing may prefer the Elysium Index ($299), which provides a methylation-based estimate at the same price with broader (if less specific) biological scope. Those requiring diagnostic-grade immune system assessment should work with a healthcare provider who can order clinical immunology panels.

How GlycanAge Compares

The comparison between GlycanAge and methylation-based tests (TruDiagnostic, Elysium, myDNAge, Chronomics) is not apples-to-apples because the underlying biomarkers are fundamentally different. Methylation clocks measure genome-wide epigenetic changes reflecting multi-system aging. GlycanAge measures IgG antibody glycosylation reflecting immune-specific aging and inflammatory status. The most comprehensive approach is to use both: methylation for broad biological aging assessment and glycan for immune system-specific aging assessment.

Among biological age tests at the $299 price point, GlycanAge competes directly with the Elysium Index. Elysium provides a broader biological age estimate through DNA methylation; GlycanAge provides a deeper immune-specific assessment through glycan analysis. TruDiagnostic TruAge Complete ($499) offers the most comprehensive single-test option with multiple methylation algorithms, organ-specific aging, and immune cell composition, though it does not include glycan analysis. No single test captures every dimension of biological aging.

Limitations and Open Questions

The narrower biological scope is both GlycanAge’s strength and its limitation. By focusing exclusively on IgG glycosylation, the test provides deep insight into immune aging but says nothing directly about epigenetic aging in other organ systems, telomere dynamics, or metabolic function. Users should understand that a “young” GlycanAge does not necessarily mean “young” biological age across all dimensions, and vice versa.

The GlycanAge algorithm and reference database are proprietary, and the company has published peer-reviewed research validating glycan-based aging biomarkers, but the consumer test’s specific implementation has less independent validation than the Horvath, GrimAge, or DunedinPACE clocks that TruDiagnostic reports. The field of glycobiology is well established in academic research but newer in consumer health applications.

Blood sample quality can be affected by acute illness, recent vaccination, hormonal fluctuations, or temporary inflammatory states, all of which can alter IgG glycan profiles. Users should test when they are in a stable health baseline rather than during or immediately after illness, stress, or other transient inflammatory triggers. The international shipping logistics may introduce variability in sample transit time and handling conditions.

What This Means for Your Health

The immune system sits at the crossroads of aging and disease. Chronic inflammation, the progressive shift from protective to destructive immune function, is implicated in all four of the chronic disease threats that Healthcare Discovery‘s longevity framework identifies as the Four Shadows. Cardiovascular disease involves inflammatory damage to arterial walls. Cancer involves immune evasion and inflammatory microenvironments. Neurodegeneration involves neuroinflammation. Metabolic dysfunction involves inflammatory disruption of insulin signaling. Measuring the immune system’s inflammatory balance is therefore measuring a central mechanism of aging itself.

GlycanAge provides this measurement through a lens that methylation clocks do not offer. Within the Five Pillars framework, the glycan-based approach is particularly responsive to Nutrition (dietary anti-inflammatory patterns), Movement (exercise-induced immune modulation), and Breathwork/Mindset (stress reduction and vagal nerve activation, which directly influence inflammatory signaling). Users who are investing in these foundational practices can use GlycanAge to track whether their immune system is responding.

The practical recommendation: GlycanAge is most valuable as a complement to, not a replacement for, methylation-based epigenetic age testing. The ideal longevity measurement stack includes a comprehensive epigenetic age test (TruDiagnostic or Elysium), a glycan-based immune age test (GlycanAge), and regular blood biomarker panels. Together, these provide a multi-dimensional view of biological aging that no single test can achieve. If budget allows only one test, methylation-based options provide broader coverage. If immune health and inflammation are your primary concerns, GlycanAge offers the most targeted insight available.

Frequently Asked Questions

What is the difference between GlycanAge and epigenetic age tests?
Epigenetic age tests (TruDiagnostic, Elysium, myDNAge) measure DNA methylation patterns across the genome to estimate biological age. GlycanAge measures glycan sugar structures on IgG antibodies to assess immune system aging and inflammatory status. The two approaches capture different biological processes and are complementary. A user can have a young epigenetic age but an old glycan age, or vice versa, because the biomarkers reflect different dimensions of aging.

How quickly can GlycanAge results change with lifestyle interventions?
IgG glycan profiles can shift within 3 to 6 months in response to lifestyle changes including improved nutrition, regular exercise, weight loss, and stress reduction. This is potentially faster than changes detectable by DNA methylation clocks. GlycanAge recommends the two-test package ($499) for baseline-plus-retest tracking, with a 3 to 6 month interval between tests to allow sufficient time for glycan remodeling.

Is GlycanAge backed by peer-reviewed research?
Yes. The glycobiology underlying GlycanAge draws on over two decades of research at the University of Zagreb and collaborating institutions, with published studies demonstrating the relationship between IgG glycan composition, aging, and inflammation. The specific consumer implementation and proprietary algorithm have less independent validation than some methylation-based clocks, but the underlying science is well-established in the academic glycobiology literature.

Can I use GlycanAge alongside an epigenetic age test?
Yes, and this combination provides the most comprehensive biological age assessment available to consumers. Methylation-based tests capture broad epigenetic aging across multiple systems. GlycanAge captures immune-specific aging and inflammatory balance. Together, they provide complementary dimensions of biological aging information that no single test covers alone. The combined cost ($299 for GlycanAge plus $299 to $499 for a methylation test) totals $598 to $798 for the most thorough consumer biological age profiling available.

Does GlycanAge test for genetic disease risk?
No. GlycanAge measures glycan patterns on antibodies, which reflect immune system function and biological aging. It does not analyze DNA sequence or genetic variants. For inherited disease risk assessment, users need genetic testing (23andMe, Nebula Genomics, Color Health). For biological age measurement through a different biomarker, epigenetic age tests (TruDiagnostic, Elysium) measure DNA methylation. Each type of test provides different, non-overlapping health information.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.